US Stock MarketDetailed Quotes

HBIO Harvard Bioscience

Watchlist

2.260
+0.020+0.89%

Close Dec 4 16:00 ET

2.260
0.0000.00%

Post 18:21 ET

98.57MMarket Cap-6848P/E (TTM)

Harvard Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-119.31%-842K

-123.82%-846K

-22.57%1.4M

1,117.71%14.03M

60.62%4.3M

571.96%4.36M

1,969.47%3.55M

191.24%1.81M

-8.72%1.15M

2,189.74%2.68M

Net income from continuing operations

-287.57%-4.8M

-198.67%-2.93M

-854.66%-4.69M

64.11%-3.42M

-9.12%-1.82M

63.61%-1.24M

-140.25%-980K

109.04%622K

-3,204.17%-9.52M

-273.36%-1.67M

Operating gains losses

----

425.56%1.31M

---403K

---373K

--373K

--0

---403K

----

Depreciation and amortization

2.02%1.82M

4.65%1.8M

3.49%1.78M

-7.62%7M

-9.38%1.78M

-8.11%1.78M

-5.96%1.72M

-6.87%1.72M

-0.60%7.58M

2.03%1.96M

Deferred tax

-12,900.00%-768K

62.41%229K

423.64%178K

181.16%336K

196.06%244K

100.50%6K

-87.88%141K

55.28%-55K

-25.45%-414K

-251.19%-254K

Other non cash items

27.14%89K

0.00%70K

107.73%280K

101.83%70K

0.00%70K

-1,392.86%-3.62M

-5,571.43%-3.83M

Change In working capital

-85.29%528K

-1,801.20%-1.58M

231.79%1.71M

69.37%4.6M

53.34%2.39M

70.22%3.59M

97.26%-83K

-162.43%-1.3M

126.65%2.72M

138.59%1.56M

-Change in receivables

-108.52%-155K

222.11%2.75M

176.27%704K

-83.05%810K

26.48%-941K

-26.45%1.82M

-58.91%855K

-161.29%-923K

211.32%4.78M

64.12%-1.28M

-Change in inventory

-196.89%-668K

-263.91%-1.13M

-111.30%-617K

504.76%1.52M

132.53%1.35M

-109.62%-225K

150.77%690K

77.68%-292K

104.30%252K

132.05%581K

-Change in payables and accrued expense

-1,517.86%-453K

-1,815.83%-2.3M

1,746.00%2.47M

139.67%555K

-12.96%853K

98.56%-28K

96.21%-120K

-105.50%-150K

-157.01%-1.4M

77.22%980K

-Change in other current assets

38.42%1.69M

46.35%-515K

3.25%-298K

248.31%1.65M

32.37%1.7M

317.11%1.22M

-544.44%-960K

33.91%-308K

207.97%474K

-22.07%1.29M

-Change in other current liabilities

----

96.43%-9K

-18.13%-430K

-117.78%-1.08M

----

48.57%-252K

-328.24%-364K

80.63%-495K

122.38%337K

-Change in other working capital

-268.95%-321K

-27.70%-378K

-116.19%-120K

227.01%1.14M

245.80%503K

216.67%190K

4.82%-296K

347.00%741K

-277.43%-896K

-153.32%-345K

Cash from discontinued investing activities

Operating cash flow

-119.31%-842K

-123.82%-846K

-22.57%1.4M

1,117.71%14.03M

60.62%4.3M

571.96%4.36M

1,969.47%3.55M

191.24%1.81M

-8.72%1.15M

2,189.74%2.68M

Investing cash flow

Cash flow from continuing investing activities

-177.06%-1.11M

173.28%458K

-178.13%-225K

-13.14%-1.8M

-351.49%-1.06M

9.28%-401K

-41.40%-625K

161.15%288K

-18.22%-1.59M

34.36%-235K

Capital expenditure reported

-25.54%-231K

-37.04%-148K

---75K

---523K

---231K

---184K

---108K

--0

----

Net PPE purchase and sale

-305.53%-880K

-58.22%-818K

-187.95%-645K

-12.45%-1.79M

-253.19%-830K

50.90%-217K

-16.97%-517K

52.44%-224K

-33.05%-1.59M

34.36%-235K

Net business purchase and sale

--0

--512K

--0

--512K

--0

Net investment purchase and sale

--0

--1.42M

--495K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-177.06%-1.11M

173.28%458K

-178.13%-225K

-13.14%-1.8M

-351.49%-1.06M

9.28%-401K

-41.40%-625K

161.15%288K

-18.22%-1.59M

34.36%-235K

Financing cash flow

Cash flow from continuing financing activities

176.51%2.1M

107.45%177K

63.53%-1.06M

-327.71%-12.13M

-50.77%-4.12M

-829.44%-2.75M

-310.90%-2.38M

-3,177.66%-2.89M

-1,025.79%-2.84M

-205.24%-2.73M

Net issuance payments of debt

181.82%2.25M

--0

63.99%-1.02M

-490.20%-10.54M

10.00%-2.25M

-492.86%-2.75M

-390.91%-2.7M

-603.72%-2.84M

-3,672.00%-1.79M

-181.97%-2.5M

Proceeds from stock option exercised by employees

--15K

-69.52%189K

-85.58%15K

61.18%930K

-10.82%206K

--0

147.01%620K

235.48%104K

-82.59%577K

-42.96%231K

Net other financing activities

---161K

95.93%-12K

69.87%-47K

-54.98%-2.52M

-349.46%-2.07M

--0

-5.73%-295K

68.86%-156K

54.98%-1.63M

46.46%-461K

Cash from discontinued financing activities

Financing cash flow

176.51%2.1M

107.45%177K

63.53%-1.06M

-327.71%-12.13M

-50.77%-4.12M

-829.44%-2.75M

-310.90%-2.38M

-3,177.66%-2.89M

-1,025.79%-2.84M

-205.24%-2.73M

Net cash flow

Beginning cash position

-6.38%4.05M

12.30%4.26M

-4.99%4.28M

-42.36%4.51M

3.81%5.34M

1.53%4.32M

-30.26%3.79M

-42.36%4.51M

-5.96%7.82M

-7.28%5.14M

Current changes in cash

-87.52%151K

-138.22%-211K

115.51%123K

102.90%95K

-205.59%-874K

107.19%1.21M

145.62%552K

66.44%-793K

-877.61%-3.28M

-112.15%-286K

Effect of exchange rate changes

290.72%370K

123.53%4K

-304.05%-151K

-742.11%-320K

47.71%-183K

-164.45%-194K

-147.22%-17K

396.00%74K

76.40%-38K

-337.50%-350K

End cash Position

-14.44%4.57M

-6.38%4.05M

12.30%4.26M

-4.99%4.28M

3.81%5.34M

1.53%4.32M

-30.26%3.79M

-42.36%4.51M

Free cash flow

-149.32%-1.95M

-161.91%-1.81M

-56.99%683K

2,775.11%11.72M

32.65%3.24M

1,813.04%3.96M

563.13%2.93M

164.63%1.59M

-427.71%-438K

1,114.11%2.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-119.31%-842K	-123.82%-846K	-22.57%1.4M	1,117.71%14.03M	60.62%4.3M	571.96%4.36M	1,969.47%3.55M	191.24%1.81M	-8.72%1.15M	2,189.74%2.68M
Net income from continuing operations	-287.57%-4.8M	-198.67%-2.93M	-854.66%-4.69M	64.11%-3.42M	-9.12%-1.82M	63.61%-1.24M	-140.25%-980K	109.04%622K	-3,204.17%-9.52M	-273.36%-1.67M
Operating gains losses	----	----	425.56%1.31M	---403K	---373K	--373K	--0	---403K	----	----
Depreciation and amortization	2.02%1.82M	4.65%1.8M	3.49%1.78M	-7.62%7M	-9.38%1.78M	-8.11%1.78M	-5.96%1.72M	-6.87%1.72M	-0.60%7.58M	2.03%1.96M
Deferred tax	-12,900.00%-768K	62.41%229K	423.64%178K	181.16%336K	196.06%244K	100.50%6K	-87.88%141K	55.28%-55K	-25.45%-414K	-251.19%-254K
Other non cash items	27.14%89K	0.00%70K	0.00%70K	107.73%280K	101.83%70K	0.00%70K	0.00%70K	0.00%70K	-1,392.86%-3.62M	-5,571.43%-3.83M
Change In working capital	-85.29%528K	-1,801.20%-1.58M	231.79%1.71M	69.37%4.6M	53.34%2.39M	70.22%3.59M	97.26%-83K	-162.43%-1.3M	126.65%2.72M	138.59%1.56M
-Change in receivables	-108.52%-155K	222.11%2.75M	176.27%704K	-83.05%810K	26.48%-941K	-26.45%1.82M	-58.91%855K	-161.29%-923K	211.32%4.78M	64.12%-1.28M
-Change in inventory	-196.89%-668K	-263.91%-1.13M	-111.30%-617K	504.76%1.52M	132.53%1.35M	-109.62%-225K	150.77%690K	77.68%-292K	104.30%252K	132.05%581K
-Change in payables and accrued expense	-1,517.86%-453K	-1,815.83%-2.3M	1,746.00%2.47M	139.67%555K	-12.96%853K	98.56%-28K	96.21%-120K	-105.50%-150K	-157.01%-1.4M	77.22%980K
-Change in other current assets	38.42%1.69M	46.35%-515K	3.25%-298K	248.31%1.65M	32.37%1.7M	317.11%1.22M	-544.44%-960K	33.91%-308K	207.97%474K	-22.07%1.29M
-Change in other current liabilities	----	96.43%-9K	-18.13%-430K	-117.78%-1.08M	----	----	48.57%-252K	-328.24%-364K	80.63%-495K	122.38%337K
-Change in other working capital	-268.95%-321K	-27.70%-378K	-116.19%-120K	227.01%1.14M	245.80%503K	216.67%190K	4.82%-296K	347.00%741K	-277.43%-896K	-153.32%-345K
Cash from discontinued investing activities
Operating cash flow	-119.31%-842K	-123.82%-846K	-22.57%1.4M	1,117.71%14.03M	60.62%4.3M	571.96%4.36M	1,969.47%3.55M	191.24%1.81M	-8.72%1.15M	2,189.74%2.68M
Investing cash flow
Cash flow from continuing investing activities	-177.06%-1.11M	173.28%458K	-178.13%-225K	-13.14%-1.8M	-351.49%-1.06M	9.28%-401K	-41.40%-625K	161.15%288K	-18.22%-1.59M	34.36%-235K
Capital expenditure reported	-25.54%-231K	-37.04%-148K	---75K	---523K	---231K	---184K	---108K	--0	--0	----
Net PPE purchase and sale	-305.53%-880K	-58.22%-818K	-187.95%-645K	-12.45%-1.79M	-253.19%-830K	50.90%-217K	-16.97%-517K	52.44%-224K	-33.05%-1.59M	34.36%-235K
Net business purchase and sale	--0	--0	--0	--512K	--0	--0	--0	--512K	--0	--0
Net investment purchase and sale	--0	--1.42M	--495K	----	----	--0	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-177.06%-1.11M	173.28%458K	-178.13%-225K	-13.14%-1.8M	-351.49%-1.06M	9.28%-401K	-41.40%-625K	161.15%288K	-18.22%-1.59M	34.36%-235K
Financing cash flow
Cash flow from continuing financing activities	176.51%2.1M	107.45%177K	63.53%-1.06M	-327.71%-12.13M	-50.77%-4.12M	-829.44%-2.75M	-310.90%-2.38M	-3,177.66%-2.89M	-1,025.79%-2.84M	-205.24%-2.73M
Net issuance payments of debt	181.82%2.25M	--0	63.99%-1.02M	-490.20%-10.54M	10.00%-2.25M	-492.86%-2.75M	-390.91%-2.7M	-603.72%-2.84M	-3,672.00%-1.79M	-181.97%-2.5M
Proceeds from stock option exercised by employees	--15K	-69.52%189K	-85.58%15K	61.18%930K	-10.82%206K	--0	147.01%620K	235.48%104K	-82.59%577K	-42.96%231K
Net other financing activities	---161K	95.93%-12K	69.87%-47K	-54.98%-2.52M	-349.46%-2.07M	--0	-5.73%-295K	68.86%-156K	54.98%-1.63M	46.46%-461K
Cash from discontinued financing activities
Financing cash flow	176.51%2.1M	107.45%177K	63.53%-1.06M	-327.71%-12.13M	-50.77%-4.12M	-829.44%-2.75M	-310.90%-2.38M	-3,177.66%-2.89M	-1,025.79%-2.84M	-205.24%-2.73M
Net cash flow
Beginning cash position	-6.38%4.05M	12.30%4.26M	-4.99%4.28M	-42.36%4.51M	3.81%5.34M	1.53%4.32M	-30.26%3.79M	-42.36%4.51M	-5.96%7.82M	-7.28%5.14M
Current changes in cash	-87.52%151K	-138.22%-211K	115.51%123K	102.90%95K	-205.59%-874K	107.19%1.21M	145.62%552K	66.44%-793K	-877.61%-3.28M	-112.15%-286K
Effect of exchange rate changes	290.72%370K	123.53%4K	-304.05%-151K	-742.11%-320K	47.71%-183K	-164.45%-194K	-147.22%-17K	396.00%74K	76.40%-38K	-337.50%-350K
End cash Position	-14.44%4.57M	-6.38%4.05M	12.30%4.26M	-4.99%4.28M	-4.99%4.28M	3.81%5.34M	1.53%4.32M	-30.26%3.79M	-42.36%4.51M	-42.36%4.51M
Free cash flow	-149.32%-1.95M	-161.91%-1.81M	-56.99%683K	2,775.11%11.72M	32.65%3.24M	1,813.04%3.96M	563.13%2.93M	164.63%1.59M	-427.71%-438K	1,114.11%2.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data